SIX Swiss Exchange · Healthcare
Invest in Tecan stock from India
Indian and foreign residents can buy Tecan (TECN) shares directly through Paasa.
By Paasa · Updated
Tecan at a glance
- Price
- CHF 233.60+CHF 0.60 (0.26%)
- Market cap
- CHF 2.96B
- Day range
- CHF 233.00 – CHF 235.60
- P/E
- -25.50
- Dividend yield
- 1.28%
- Volume
- 6.70K
- 1 month
- +20.16%
- 6 months
- +83.94%
- YTD
- +81.79%
- 1 year
- +60.55%
- 5 years
- -56.05%
Tecan statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 882.5M | CHF 934.3M | CHF 1.1B | CHF 1.1B | CHF 946.6M |
| Gross profit | CHF 280.2M | CHF 320.6M | CHF 390.5M | CHF 405.3M | CHF 388.0M |
| Operating income | CHF 25.2M | CHF 75.6M | CHF 136.0M | CHF 146.0M | CHF 141.1M |
| Net income | −CHF 110.7M | CHF 67.7M | CHF 132.1M | CHF 121.1M | CHF 121.7M |
| Earnings per share | −CHF 8.74 | CHF 5.29 | CHF 10.34 | CHF 9.53 | CHF 9.95 |
| EBITDA | CHF 86.2M | CHF 147.8M | CHF 205.6M | CHF 210.9M | CHF 201.2M |
| Total assets | CHF 1.7B | CHF 2.1B | CHF 2.1B | CHF 2.2B | CHF 2.0B |
| Total debt | CHF 218.3M | CHF 321.3M | CHF 316.1M | CHF 307.7M | CHF 313.7M |
| Cash and short-term investments | CHF 311.4M | CHF 406.0M | CHF 366.4M | CHF 293.2M | CHF 241.9M |
| Shareholders' equity | CHF 1.2B | CHF 1.4B | CHF 1.3B | CHF 1.4B | CHF 1.2B |
| Operating cash flow | CHF 138.0M | CHF 148.5M | CHF 160.6M | CHF 127.5M | CHF 165.8M |
| Free cash flow | CHF 102.7M | CHF 117.9M | CHF 125.6M | CHF 91.2M | CHF 126.1M |
| Capital expenditure | −CHF 35.3M | −CHF 30.7M | −CHF 34.9M | −CHF 36.2M | −CHF 39.7M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| BB Biotech | BION.SW | CHF 51.40 | CHF 2.83B |
| Medacta | MOVE.SW | CHF 115.80 | CHF 2.31B |
| SKAN | SKAN.SW | CHF 69.60 | CHF 1.56B |
| PolyPeptide | PPGN.SW | CHF 44.05 | CHF 1.45B |
| Aevis Victoria | AEVS.SW | CHF 15.75 | CHF 1.33B |
| Medartis | MED.SW | CHF 85.90 | CHF 1.07B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Tecan from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search TECN and buy
Find Tecan by name or by its ticker, TECN, and place your order.
Why invest in Tecan from India
What Tecan does
Tecan Group AG, established in 1980 and headquartered in Männedorf, Switzerland, specializes in providing cutting-edge laboratory instruments and holistic solutions. The company caters to a broad spectrum of clients, including pharmaceutical and biotechnology corporations, university research departments, and forensic and diagnostic laboratories. Tecan operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Tecan stock from India?
Yes. Indian residents and NRIs can buy Tecan (TECN) shares directly through Paasa. Tecan is listed on the SIX Swiss Exchange, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Tecan shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.